Ferroptosis: A Key Mechanism in Alcohol-Induced Mitochondrial Dysfunction and Oxidative Stress

Alcoholic liver disease (ALD) is a complex condition marked by mitochondrial dysfunction, oxidative stress, and hepatocellular death. Among the various mechanisms involved, ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, has emerged as a critical contributor. Alcohol metabolism increases reactive oxygen species (ROS), depletes glutathione, and promotes lipid peroxidation, which jointly trigger ferroptosis and exacerbate liver injury. Recent studies highlight the significant role of hypoxia-inducible factors (HIFs), particularly HIF-1α and HIF-2α, in regulating ferroptosis during ALD. HIF-1α promotes iron accumulation by enhancing iron uptake and reducing iron export, thereby sensitizing hepatocytes to ferroptosis. In contrast, HIF-2α demonstrates a context-dependent influence on iron homeostasis and cellular responses to hypoxic stress. These findings point to a complex regulatory network involving mitochondrial damage, ROS generation, and iron metabolism. Despite growing evidence, the interplay among ROS, HIFs, and ferroptosis in ALD pathogenesis remains insufficiently defined. The dual roles of HIF isoforms and their effects on mitochondrial function and iron regulation require further investigation. Additionally, therapeutic strategies targeting ferroptosis or HIF activity remain largely unexplored in clinical practice. Continued research is needed to clarify the molecular pathways connecting HIFs and ferroptosis in ALD. Developing ferroptosis inhibitors and modulators of HIF activity may offer promising therapeutic options, and preclinical and clinical studies should determine the appropriate dosing and safety profiles. A deeper understanding of these mechanisms may enable targeted interventions that reduce liver injury and improve outcomes in individuals with ALD.

Authors

Institutions

Publication Details

Journal
ACS Pharmacology & Translational Science
Published
2026-03-04
DOI
https://doi.org/10.1021/acsptsci.5c00759
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ferroptosis: A Key Mechanism in Alcohol-Induced Mitochondrial Dysfunction and Oxidative Stress

Venkata Reddy, Khajamohiddin Syed, Padmavathi Pannuru, Subhasish Maity et al.
ACS Pharmacology & Translational Science
Ferroptosis and cancer prognosis
article

Ferroptosis: A Key Mechanism in Alcohol-Induced Mitochondrial Dysfunction and Oxidative Stress

Venkata Reddy, Khajamohiddin Syed, Padmavathi Pannuru, Subhasish Maity, Ayantika Santra, Gouthami Kuruvalli, Jaesool Shim, Nagajyothi Chidanandha Patnamsetty
article en

Abstract

Alcoholic liver disease (ALD) is a complex condition marked by mitochondrial dysfunction, oxidative stress, and hepatocellular death. Among the various mechanisms involved, ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, has emerged as a critical contributor. Alcohol metabolism increases reactive oxygen species (ROS), depletes glutathione, and promotes lipid peroxidation, which jointly trigger ferroptosis and exacerbate liver injury. Recent studies highlight the significant role of hypoxia-inducible factors (HIFs), particularly HIF-1α and HIF-2α, in regulating ferroptosis during ALD. HIF-1α promotes iron accumulation by enhancing iron uptake and reducing iron export, thereby sensitizing hepatocytes to ferroptosis. In contrast, HIF-2α demonstrates a context-dependent influence on iron homeostasis and cellular responses to hypoxic stress. These findings point to a complex regulatory network involving mitochondrial damage, ROS generation, and iron metabolism. Despite growing evidence, the interplay among ROS, HIFs, and ferroptosis in ALD pathogenesis remains insufficiently defined. The dual roles of HIF isoforms and their effects on mitochondrial function and iron regulation require further investigation. Additionally, therapeutic strategies targeting ferroptosis or HIF activity remain largely unexplored in clinical practice. Continued research is needed to clarify the molecular pathways connecting HIFs and ferroptosis in ALD. Developing ferroptosis inhibitors and modulators of HIF activity may offer promising therapeutic options, and preclinical and clinical studies should determine the appropriate dosing and safety profiles. A deeper understanding of these mechanisms may enable targeted interventions that reduce liver injury and improve outcomes in individuals with ALD.

ACS Pharmacology & Translational ScienceVol. 9(3)
University of Zululand (ZA), Department of Physics, Mathematics and Informatics (BY), HUN-REN Centre for Agricultural Research (HU), Bangalore University (IN), Yeungnam University (KR), REVA University (IN)
Zero hunger
Openalex Percentile: Top 34%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.